MohamedAl-IbrahimMD

Infectious Disease • Baltimore, MD

Senior Investigator, Pharmaron, Clinical Pharmacology Center

Join to view full profile

Dr. Al-Ibrahim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Al-Ibrahim's full profile

Already have an account?

Office
827 Linden Ave
Baltimore, MD 21201
Phone+1 410-225-8000

Fax+1 410-706-8963

Education & Training

NYU Grossman School of MedicineFellowship, Infectious Disease, 1973 - 1975
NYU Grossman School of MedicineResidency, Internal Medicine, 1973 - 1974
University of MarylandResidency, Internal Medicine, 1971 - 1972
University of Maryland Medical Center Midtown CampusResidency, Internal Medicine, 1970 - 1971
University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1969 - 1970
University of Baghdad College of MedicineClass of 1967

Certifications & Licensure

MD State Medical License 1973 - 2026
NY State Medical License 1974 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV) Start of enrollment: 2009 Feb 01
Completed
Phase 1, Phase 2
ACE393-103 Vaccination Challenge Study Start of enrollment: 2008 Oct 01
Unknown status
Phase 2
Norwalk Vaccine Study Start of enrollment: 2009 Aug 04
Completed
Phase 1, Phase 2
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers Start of enrollment: 2013 May 01
Completed
Phase 1
Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) Start of enrollment: 2012 Mar 17
Completed
Phase 1
Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for Injection Start of enrollment: 2019 Apr 29
Completed
Phase 1
A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004 Start of enrollment: 2020 Jan 09
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

6 citations
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Jesse Nussbaum, Xin Cao, Radha A Railkar, Jeffrey R Sachs, Daniel S Spellman
Vaccine. 2023-10-20
6 citations
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea i...
Rahsan Erdem, Gwen Ambler, Mohamed S. Al-Ibrahim, Katarzyna Fraczek, Steven D Dong
Plos Neglected Tropical Diseases. 2021-11-18
8 citations
A Multipurpose First-in-Human Study With the Novel CXCR7 Antagonist ACT-1004-1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker.
Christine Huynh, Andrea Henrich, Daniel S. Strasser, Marie-Laure Boof, Mohamed Al-Ibrahim
Clinical Pharmacology and Therapeutics. 2021-06-01

Press Mentions

Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort FreeJune 7th, 2005
Immuron Announces First Patients Enrolled in Travelan® Clinical StudyJuly 26th, 2023